Top 5 Stocks to Buy Now
→ Stranded On The Flood Plains of History (From Porter & Company) (Ad)tc pixel Free SBRA Stock Alerts

Sabra Healthcare REIT (SBRA) Competitors

Sabra Healthcare REIT logo
$18.63 +0.36 (+1.97%)
As of 04:00 PM Eastern
Compare

SBRA vs. CTRE, LTC, NHI, OHI, and VTR

Should you buy Sabra Healthcare REIT stock or one of its competitors? MarketBeat compares Sabra Healthcare REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sabra Healthcare REIT include CareTrust REIT (CTRE), LTC Properties (LTC), National Health Investors (NHI), Omega Healthcare Investors (OHI), and Ventas (VTR). These companies are all part of the "reit - eqty trust - other" industry.

How does Sabra Healthcare REIT compare to CareTrust REIT?

Sabra Healthcare REIT (NASDAQ:SBRA) and CareTrust REIT (NYSE:CTRE) are both mid-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

CareTrust REIT has lower revenue, but higher earnings than Sabra Healthcare REIT. CareTrust REIT is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.07$155.61M$0.6329.57
CareTrust REIT$476.39M19.23$320.54M$1.5624.85

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 87.8% of CareTrust REIT shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by insiders. Comparatively, 0.7% of CareTrust REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sabra Healthcare REIT presently has a consensus target price of $21.30, suggesting a potential upside of 14.33%. CareTrust REIT has a consensus target price of $44.82, suggesting a potential upside of 15.60%. Given CareTrust REIT's stronger consensus rating and higher possible upside, analysts clearly believe CareTrust REIT is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
CareTrust REIT
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.4%. CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.0%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT has increased its dividend for 3 consecutive years.

In the previous week, Sabra Healthcare REIT had 3 more articles in the media than CareTrust REIT. MarketBeat recorded 6 mentions for Sabra Healthcare REIT and 3 mentions for CareTrust REIT. CareTrust REIT's average media sentiment score of 0.75 beat Sabra Healthcare REIT's score of -0.10 indicating that CareTrust REIT is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareTrust REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CareTrust REIT has a net margin of 64.10% compared to Sabra Healthcare REIT's net margin of 19.22%. CareTrust REIT's return on equity of 8.65% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
CareTrust REIT 64.10%8.65%6.66%

Sabra Healthcare REIT has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, CareTrust REIT has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Summary

CareTrust REIT beats Sabra Healthcare REIT on 14 of the 20 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to LTC Properties?

LTC Properties (NYSE:LTC) and Sabra Healthcare REIT (NASDAQ:SBRA) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

Sabra Healthcare REIT has higher revenue and earnings than LTC Properties. LTC Properties is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LTC Properties$262.85M7.26$117.97M$2.4715.11
Sabra Healthcare REIT$774.63M6.07$155.61M$0.6329.57

LTC Properties has a net margin of 38.99% compared to Sabra Healthcare REIT's net margin of 19.22%. LTC Properties' return on equity of 10.87% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
LTC Properties38.99% 10.87% 6.03%
Sabra Healthcare REIT 19.22%5.60%2.84%

69.3% of LTC Properties shares are owned by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are owned by institutional investors. 2.2% of LTC Properties shares are owned by company insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

LTC Properties pays an annual dividend of $2.28 per share and has a dividend yield of 6.1%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.4%. LTC Properties pays out 92.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

LTC Properties presently has a consensus target price of $40.60, suggesting a potential upside of 8.82%. Sabra Healthcare REIT has a consensus target price of $21.30, suggesting a potential upside of 14.33%. Given Sabra Healthcare REIT's higher probable upside, analysts clearly believe Sabra Healthcare REIT is more favorable than LTC Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LTC Properties
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.63
Sabra Healthcare REIT
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27

LTC Properties has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

In the previous week, Sabra Healthcare REIT had 5 more articles in the media than LTC Properties. MarketBeat recorded 6 mentions for Sabra Healthcare REIT and 1 mentions for LTC Properties. LTC Properties' average media sentiment score of 0.00 beat Sabra Healthcare REIT's score of -0.10 indicating that LTC Properties is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LTC Properties
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sabra Healthcare REIT
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

LTC Properties beats Sabra Healthcare REIT on 10 of the 19 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to National Health Investors?

Sabra Healthcare REIT (NASDAQ:SBRA) and National Health Investors (NYSE:NHI) are both mid-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 62.5% of National Health Investors shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 2.7% of National Health Investors shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Sabra Healthcare REIT has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, National Health Investors has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

In the previous week, Sabra Healthcare REIT had 6 more articles in the media than National Health Investors. MarketBeat recorded 6 mentions for Sabra Healthcare REIT and 0 mentions for National Health Investors. National Health Investors' average media sentiment score of 1.90 beat Sabra Healthcare REIT's score of -0.10 indicating that National Health Investors is being referred to more favorably in the news media.

Company Overall Sentiment
Sabra Healthcare REIT Neutral
National Health Investors Very Positive

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.4%. National Health Investors pays an annual dividend of $3.68 per share and has a dividend yield of 5.0%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. National Health Investors pays out 118.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Sabra Healthcare REIT presently has a consensus target price of $21.30, indicating a potential upside of 14.33%. National Health Investors has a consensus target price of $84.57, indicating a potential upside of 15.72%. Given National Health Investors' stronger consensus rating and higher probable upside, analysts plainly believe National Health Investors is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
National Health Investors
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88

Sabra Healthcare REIT has higher revenue and earnings than National Health Investors. National Health Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.07$155.61M$0.6329.57
National Health Investors$375.63M9.43$142.18M$3.1023.57

National Health Investors has a net margin of 36.86% compared to Sabra Healthcare REIT's net margin of 19.22%. National Health Investors' return on equity of 9.82% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
National Health Investors 36.86%9.82%5.35%

Summary

National Health Investors beats Sabra Healthcare REIT on 12 of the 19 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Omega Healthcare Investors?

Sabra Healthcare REIT (NASDAQ:SBRA) and Omega Healthcare Investors (NYSE:OHI) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by insiders. Comparatively, 1.5% of Omega Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Omega Healthcare Investors has higher revenue and earnings than Sabra Healthcare REIT. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.07$155.61M$0.6329.57
Omega Healthcare Investors$1.19B11.63$572.03M$2.0722.45

In the previous week, Sabra Healthcare REIT and Sabra Healthcare REIT both had 6 articles in the media. Omega Healthcare Investors' average media sentiment score of 0.92 beat Sabra Healthcare REIT's score of -0.10 indicating that Omega Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Omega Healthcare Investors
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.4%. Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 5.8%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Omega Healthcare Investors pays out 129.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Sabra Healthcare REIT has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Omega Healthcare Investors has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Sabra Healthcare REIT presently has a consensus target price of $21.30, suggesting a potential upside of 14.33%. Omega Healthcare Investors has a consensus target price of $48.31, suggesting a potential upside of 3.93%. Given Sabra Healthcare REIT's higher possible upside, equities analysts clearly believe Sabra Healthcare REIT is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
Omega Healthcare Investors
1 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.29

Omega Healthcare Investors has a net margin of 51.14% compared to Sabra Healthcare REIT's net margin of 19.22%. Omega Healthcare Investors' return on equity of 11.86% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
Omega Healthcare Investors 51.14%11.86%6.10%

Summary

Omega Healthcare Investors beats Sabra Healthcare REIT on 12 of the 17 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Ventas?

Sabra Healthcare REIT (NASDAQ:SBRA) and Ventas (NYSE:VTR) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 94.2% of Ventas shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 0.5% of Ventas shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.4%. Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.4%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas pays out 378.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has increased its dividend for 1 consecutive years. Sabra Healthcare REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Ventas had 8 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 14 mentions for Ventas and 6 mentions for Sabra Healthcare REIT. Ventas' average media sentiment score of 1.21 beat Sabra Healthcare REIT's score of -0.10 indicating that Ventas is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ventas
10 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sabra Healthcare REIT presently has a consensus target price of $21.30, suggesting a potential upside of 14.33%. Ventas has a consensus target price of $96.00, suggesting a potential upside of 12.33%. Given Sabra Healthcare REIT's higher possible upside, equities analysts clearly believe Sabra Healthcare REIT is more favorable than Ventas.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
Ventas
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

Sabra Healthcare REIT has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Ventas has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market.

Ventas has higher revenue and earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.07$155.61M$0.6329.57
Ventas$5.83B7.12$251.38M$0.55155.38

Sabra Healthcare REIT has a net margin of 19.22% compared to Ventas' net margin of 4.25%. Sabra Healthcare REIT's return on equity of 5.60% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
Ventas 4.25%2.09%0.96%

Summary

Ventas beats Sabra Healthcare REIT on 10 of the 19 factors compared between the two stocks.

Get Sabra Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBRA vs. The Competition

Export
MetricSabra Healthcare REITREIT IndustryFinance SectorNASDAQ Exchange
Market Cap$4.61B$9.88B$13.98B$12.39B
Dividend Yield6.57%4.99%5.76%5.83%
P/E Ratio29.5744.4821.4622.20
Price / Sales6.075.30143.70110.15
Price / Cash13.3014.1619.5254.51
Price / Book1.652.092.256.50
Net Income$155.61M$227.95M$1.14B$336.88M
7 Day Performance0.38%0.19%-0.21%-0.22%
1 Month Performance-10.09%3.30%1.13%0.77%
1 Year Performance0.22%12.15%15.50%31.57%

Sabra Healthcare REIT Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBRA
Sabra Healthcare REIT
2.9135 of 5 stars		$18.63
+2.0%		$21.30
+14.3%		+0.1%$4.61B$774.63M29.5740
CTRE
CareTrust REIT
3.7651 of 5 stars		$37.00
+0.4%		$44.45
+20.2%		+24.5%$8.71B$476.39M23.7220
LTC
LTC Properties
3.8057 of 5 stars		$36.58
-0.7%		$40.60
+11.0%		+4.5%$1.89B$262.85M14.8120
NHI
National Health Investors
4.4697 of 5 stars		$70.73
-1.9%		$84.57
+19.6%		+0.1%$3.49B$375.63M22.8220
OHI
Omega Healthcare Investors
2.7519 of 5 stars		$45.16
-1.3%		$49.00
+8.5%		+22.1%$13.63B$1.19B21.8250

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SBRA) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel